U.S. Army Medical Readiness Contracting Office, West (MRCO-West)

U.S. Army Medical Readiness Contracting Office, West (MRCO-West)

Close: May 7, 2026

This is a Sources Sought notice seeking FDA-approved F-18 Fludeoxyglucose (FDG) unit dose radiopharmaceuticals for the Dwight David Eisenhower Army Medical Center Nuclear Medicine Department. The contractor must be an FDA-approved radioisotope provider and supply an estimated 450 unit doses with specific delivery and calibration requirements. The notice was issued by the U.S. Army Health Contracting Activity to identify potential suppliers for this medical supply requirement.

U.S. Army Medical Readiness Contracting Office, West (MRCO-West)

Close: May 5, 2026

The Department of the Army Medical Command is seeking market information for five automated apheresis systems for the Carl R. Darnall Army Medical Center. This Sources Sought notice is intended for preliminary planning and market survey purposes to identify interested offerors. No formal contract will be awarded directly from this notice, and responses are used to inform future procurement strategies.

U.S. Army Medical Readiness Contracting Office, West (MRCO-West)

Close: May 6, 2026

The Medical Readiness Contracting Office-West (MRCO-W) is conducting market research to identify vendors capable of providing a Cost-Per-Test lease analyzer and reagents for detecting C. difficile and H. pylori at Carl R. Darnall Army Medical Center. The anticipated procurement involves a 12-month base period with four 12-month options, with performance expected to begin in October 2026. Interested parties must submit Statements of Capability by the May 2026 deadline to assist the government in its acquisition strategy.